Literature DB >> 17038317

Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas.

Katarzyna Modzelewska1, Laura P Newman, Radhika Desai, Patricia J Keely.   

Abstract

We previously showed that activation of the small GTPase Cdc42 promotes breast cell migration on a collagen matrix. Here we further define the signaling pathways that drive this response and show that Cdc42-mediated migration relies on the adaptor molecule p130(Cas). Activated Cdc42 enhanced p130(Cas) phosphorylation and its binding to Crk. Cdc42-driven migration and p130(Cas) phosphorylation were dependent on the Cdc42 effector Ack1 (activated Cdc42-associated kinase). Ack1 formed a signaling complex that also included Cdc42, p130(Cas), and Crk, formation of which was regulated by collagen stimulation. The interaction between Ack1 and p130(Cas) occurred through their respective SH3 domains, while the substrate domain of p130(Cas) was the major site of Ack1-dependent phosphorylation. Signaling through this complex is functionally relevant, because treatment with either p130(Cas) or Ack1 siRNA blocked Cdc42-induced migration. These results suggest that Cdc42 exerts its effects on cell migration in part through its effector Ack1, which regulates p130(Cas) signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038317     DOI: 10.1074/jbc.M604342200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.

Authors:  Boon Tin Chua; Shu Jing Lim; Su Chin Tham; Wei Jie Poh; Axel Ullrich
Journal:  Mol Oncol       Date:  2010-03-19       Impact factor: 6.603

Review 2.  Manipulation of Focal Adhesion Signaling by Pathogenic Microbes.

Authors:  Korinn N Murphy; Amanda J Brinkworth
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

3.  Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.

Authors:  Kiran Mahajan; Sridevi Challa; Domenico Coppola; Harshani Lawrence; Yunting Luo; Harsukh Gevariya; Weiwei Zhu; Y Ann Chen; Nicholas J Lawrence; Nupam P Mahajan
Journal:  Prostate       Date:  2010-09-01       Impact factor: 4.104

Review 4.  Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

5.  Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Barbara P Craddock; Deborah A Brown; W Todd Miller
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

6.  Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Authors:  Colleen S Curran; Esteban R Carrillo; Suzanne M Ponik; Patricia J Keely
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-01       Impact factor: 4.860

7.  Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis.

Authors:  Jin-Shui Zhu; Hua Guo; Ming-Quan Song; Guo-Qiang Chen; Qun Sun; Qiang Zhang
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

Review 8.  Impact of heat-shock protein 90 on cancer metastasis.

Authors:  Shinji Tsutsumi; Kristin Beebe; Len Neckers
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

9.  Regulation of Ack1 localization and activity by the amino-terminal SAM domain.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Deborah A Brown; W Todd Miller
Journal:  BMC Biochem       Date:  2010-10-27       Impact factor: 4.059

10.  Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.

Authors:  Nupam P Mahajan; Yuanbo Liu; Samarpan Majumder; Maria R Warren; Carol E Parker; James L Mohler; H Shelton Earp; Young E Whang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.